A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II–III malignant pleural mesothelioma Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results Malignant Pleural Mesothelioma: Surgical Management in 285 Patients The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experience Malignant mesothelioma 2008. Current concepts in malignant pleural mesothelioma. Newer issues in mesothelioma chemotherapy. Spindle cell tumors of the pleura: differential diagnosis. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Integration of multimodality approaches in the management of malignant pleural mesothelioma. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
|
Surgical Studies - Pleural
Believe in a Cure!
Contact us for a free copy of the book "100 Questions & Answers about mesothelioma."
(877) END-MESO
(877) 363-6376


